Statistics

Total Visits

Views
Open label phase II clinical trial of orteronel (TAK700) in metastatic or advanced nonresectable granulosa cell ovarian tumors: The Greko II study-GETHI 20130146

Select a period of time:

Number of views in the range

Views
Open label phase II clinical trial of orteronel (TAK700) in metastatic or advanced nonresectable granulosa cell ovarian tumors: The Greko II study-GETHI 20130128

Views

Views
January 20253
February 20253
March 202516
April 20253
May 20251
June 20252
July 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore14
United States11
Spain1
United Kingdom1
 

Top cities views

Views
Council Bluffs1
San Francisco1